DNA Methylation Market (By Technology: Bisulphite DNA Modification, Immunoprecipitation of Methylated DNA; By Application; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Published Date : Sep 2022 | No. of Pages : 150+ Pages | Category : Healthcare

The global DNA methylation market was surpassed at USD 1.72 billion in 2021 and is expected to hit around USD 8.05 billion by 2030, growing at a CAGR of 18.71% from 2022 to 2030.

DNA Methylation Market Size 2021 to 2030

DNA methylation is a process by which methyl groups are added to the target DNA molecule. The process results in the modification of gene expression and leads to the silencing of the required genes. The process is known to play a pivotal role in various cellular processes, such as cell differentiation, genomic imprinting, embryogenesis, and X-chromosome inactivation.

Moreover, the technology is an epigenetic form of gene regulation that is naturally critical to life processes, especially during gestational and postnatal developmental processes. It also primarily helps in the regulation and monitoring of the cell cycle along with cellular differentiation processes. Further, the process is also known to be featured in a definite pattern along with various disorders such as cancer, neurodegenerative disorders, and cardiovascular ailments.

The unprecedented rise in demand for epigenetics-based treatment strategies, along with extensive commercialization of nucleic acid-based diagnostic tests & kits is expected to accelerate the market growth. Moreover, the adaptive utility of next-generation sequencing (NGS) based techniques in drug development, gene therapy, and clinical research is also projected to drive the market during the forecast period.

Cancer progression is associated with genetic expressions and conditions. A recent research study on tissue-specific methylation suggests that DNA hypo-methylation helps enhance tumor transformation in a variety of pathways. Further, newer research has revealed that genomic 5-hydroxymethylcytosine is an intermediate in DNA de-methylation that results in cancer-related losses. Furthermore, decreased hydroxyl and DNA methylation both play important roles in carcinogenesis. There are many commercially available kits and panels to effectively identify specific sites that could give specific insights into the caused cancer condition. For instance, In May 2022, Twist Bioscience Corporation launched the Twist Human Methylome Panel, to aid applications in cancer metastasis, human development, and functional genetics. The panel facilitates the effective identification of a robust, collated set of genome-wide methylated cytosine, CpG sites and guanines, for the detection of biologically significant methylation signatures.

Moreover, the process also enables the detection of deoxyribonucleic acid fragments which are originated from tumor cells. The novel technology not only detects genomic alterations in the nucleic acid molecules released by tumor cells but also monitors the progression or response of a tumor to a therapeutic regime.

A gradual rise in the number of types of cancers, and numerous clinical trials conducted across the globe are projected to offer a favorable environment for market growth. There is also growing demand for kits-based DNA methylation due to its ease of use and superior outcomes. For instance, The Nucleo-pore DNA Methylation Kit facilitates a combination of DNA denaturation and bisulfite conversion in a single process. The uracils are essentially transformed into thymines, and the residues into cytosines using a PCR cycle.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 1.72 billion  
Revenue Forecast by 2030 USD 8.05 billion 
Growth rate from 2022 to 2030 CAGR of 18.71%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Technology, Application, End use, Product, Region
Companies Covered

New England Biolabs, Sysmex Corporation, Abcam plc., F. Hoffmann-La Roche Ltd., Diagenode Diagnostics S.A., Thermo-Fisher Scientific Inc., Agilent Technologies Inc., BioRad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Active Motif, Inc., Illumina Inc., EpiGentek Group Inc., Pacific Biosciences Inc., New England Biolabs Inc., Merck KGaA, Zymo Research Corporation, F. Hoffmann-La Roche Ltd., PerkinElmer Inc.

 

Key Players

  • New England Biolabs
  • Sysmex Corporation
  • Abcam plc.
  • F. Hoffmann-La Roche Ltd.
  • Diagenode Diagnostics S.A.
  • Thermo-Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • BioRad Laboratories Inc.
  • Exact Sciences Corporation 
  • QIAGEN N.V.
  • Active Motif, Inc.
  • Illumina Inc.
  • EpiGentek Group Inc.
  • Pacific Biosciences Inc.
  • New England Biolabs Inc. 
  • Merck KGaA
  • Zymo Research Corporation
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.

Market Segmentation

  • By Technology
    • Bisulphite DNA modification
    • Immunoprecipitation of methylated DNA
    • High resolution melt analysis
    • Other
  • By Application
    • DNA sequencing
    • Gene therapy
    • Diagnostic Immunoassay
    • Oncology
    • Research
    • Others
  • By End use
    • Hospital & Diagnostic laboratories
    • Pharmaceutical & Biotechnology companies
    • Research & Academia
  • By Product
    • Enzymes & reagents
    • Kits
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Featured Research Reports

  • Featured Research Reports

    Neuro-navigation Systems Market (By Product Type: Optical System, Electromagnetic System; By Application; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Forensic Genomics Market (By Solution: Kits, Analyzers & Sequencers, Software, Consumables; By Method; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Personalized Medicine Biomarkers Market (By Technology: Liquid Biopsy; By Application: Oncology, Cardiology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    3D Printed Prosthetics Market (By Product Type: Sockets, Limbs, Joints, Covers; By Material; By End-Use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Vulvovaginal Candidiasis Treatment Market (By Drug Type: Clotrimazole, Nystatin, Fluconazole; By Route Of Administration; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...